These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8389668)

  • 61. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.
    Imdahl A; Jenkner S; Brink I; Nitzsche E; Stoelben E; Moser E; Hasse J
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):324-9. PubMed ID: 11463551
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study.
    Chin R; McCain TW; Miller AA; Dunagan DP; Acostamadiedo J; Douglas Case L; Harkness BA; Adler LP; Haponik EF
    Lung Cancer; 2002 Jul; 37(1):1-6. PubMed ID: 12057859
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
    Lai DT; Fulham M; Stephen MS; Chu KM; Solomon M; Thompson JF; Sheldon DM; Storey DW
    Arch Surg; 1996 Jul; 131(7):703-7. PubMed ID: 8678767
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Greven KM; Keyes JW; Williams DW; McGuirt WF; Joyce WT
    Cancer; 1999 Jul; 86(1):114-8. PubMed ID: 10391570
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
    Nomori H; Shibata H; Uno K; Iyama K; Honda Y; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
    J Thorac Oncol; 2008 Dec; 3(12):1427-32. PubMed ID: 19057268
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Positron emission tomography/computed tomography for lung cancer staging].
    Ladrón de Guevara H D; Furnaro L F; Yévenes A S; Clavero R JM; Lazo P D; Rodríguez D P; Piottante B A; Pefaur D R; Pardo B C
    Rev Med Chil; 2015 Jan; 143(1):22-9. PubMed ID: 25860265
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.
    Patz EF; Lowe VJ; Goodman PC; Herndon J
    Chest; 1995 Dec; 108(6):1617-21. PubMed ID: 7497771
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
    Kelly RF; Tran T; Holmstrom A; Murar J; Segurola RJ
    Chest; 2004 Apr; 125(4):1413-23. PubMed ID: 15078754
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
    Bradley JD; Dehdashti F; Mintun MA; Govindan R; Trinkaus K; Siegel BA
    J Clin Oncol; 2004 Aug; 22(16):3248-54. PubMed ID: 15310768
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Satellite PET and lung cancer: a prospective study in surgical patients.
    Slosman DO; Spiliopoulos A; Couson F; Nicod L; Louis O; Lemoine R; Donath A; Junod AF
    Nucl Med Commun; 1993 Nov; 14(11):955-61. PubMed ID: 8290167
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J; Milleron B; Vaylet F; Grahek D; Lebeau B; Mangiapan G; Bonardel G; de Labriolle-Vaylet C; Meignan M; Carette MF; Talbot JN; Housset B
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
    Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma.
    Hellwig D; Graeter TP; Ukena D; Georg T; Kirsch CM; Schäfers HJ
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):892-9. PubMed ID: 15573074
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Positron emission tomography of the thorax. The current clinical status].
    Knopp MV; Bischoff H; Oberdorfer F; van Kaick G
    Radiologe; 1992 Jun; 32(6):290-5. PubMed ID: 1641486
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.
    Zhao DS; Valdivia AY; Li Y; Blaufox MD
    Semin Nucl Med; 2002 Oct; 32(4):272-5. PubMed ID: 12524651
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of positron emission tomography in oncology.
    Glaspy JA; Hawkins R; Hoh CK; Phelps ME
    Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
    [TBL] [Abstract][Full Text] [Related]  

  • 79. FDG-PET in the selection of brain lesions for biopsy.
    Hanson MW; Glantz MJ; Hoffman JM; Friedman AH; Burger PC; Schold SC; Coleman RE
    J Comput Assist Tomogr; 1991; 15(5):796-801. PubMed ID: 1885797
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma.
    Ichiya Y; Kuwabara Y; Sasaki M; Yoshida T; Omagari J; Akashi Y; Kawashima A; Fukumura T; Masuda K
    Ann Nucl Med; 1996 May; 10(2):193-200. PubMed ID: 8800448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.